Gastric cancer (GC) is among the most fatal cancers in China. MicroRNAs (miRNAs) are versatile regulators during GC development and progression. miR-491-5p has been demonstrated to act as a tumor suppressor in several types of cancer. However, the role of miR-491-5p in GC metastasis remains unknown. Here, we found that miR-491-5p was significantly decreased in GC tissues compared with adjacent non-cancer- 
which contributes to the low 5-year survival rate. 1, 7 The epithelialmesenchymal transition (EMT) is a critical step in the initiation of GC migration and invasion. E-cadherin is a hallmark of epithelial integrity and a major component of adherens junctions. Mutations and methylations of E-cadherin frequently occur in GC. 7 SNAIL is known to be a transcriptional repressor of E-cadherin. Overexpression of SNAIL inhibits the transcription of E-cadherin, induces EMT and favors tumor metastasis. Our previous findings also demonstrated that SNAIL acts as a promoter of GC growth and metastasis. 8 Fibroblast growth factor receptor (FGFR4) is a tyrosine kinase and cell surface receptor for fibroblast growth factor 19 (FGF19). The FGF19-FGFR4 axis causes a loss of b-catenin-E-cadherin binding, which indicates that this axis could possibly potentiate tumor metastasis. 9 In GC, FGFR4 is reported to be highly expressed in cancerous tissues and to be associated with cancer progression. Overexpression of FGFR4 affects GC cell proliferation and apoptosis. 10 Here,
we further elaborate the functions of SNAIL and FGFR4, and how these genes are regulated in GC.
In the present study, we investigate the roles of miR-491-5p in GC development and progression, particularly in GC metastasis. We identified SNAIL as a direct target of miR-491-5p, and FGFR4 was inhibited indirectly by miR-491-5p. miR-491-5p-mediated inhibition of these 2 genes resulted in the suppression of EMT and GC metastasis.
| MATERIAL AND METHODS

| Clinical samples
Forty pairs of frozen gastric cancer tissues and matched nonmalignant tissues were obtained from the Southwest Hospital of the Third
Military Medical University (Chongqing, China). None of these patients had received chemotherapy or radiotherapy before surgery.
Patients with infectious diseases, autoimmune diseases or multipleprimary cancers were excluded from the study. All samples were collected with the consent of the patients, and the experiments were approved by the Ethics Review Board of the Third Military Medical University.
| Cell culture
The FCS at 37°C with 5% CO 2 .
| RNA isolation and quantitative real-time PCR
Total RNA was extracted using the Trizol (Invitrogen, Carlsbad, CA, USA) method. The expression of miRNA was measured using a TaqMan MicroRNA Reverse Transcription Kit and TaqMan Micro-RNA Assays (Applied Biosystems, Foster City, CA, USA). The data were normalized to the endogenous U6 snRNA. For mRNA detection, reverse transcription was performed using PrimeScript RT Master Mix (TaKaRa, Dalian, China). Real-time PCR was performed using SYBR (Toyobo, Japan). The data were normalized to GAPDH. The primer sequences are listed in Table S1 . All quantitative real-time PCR (qRT-PCR) reactions were performed in triplicate using a BioRad CFX96 real-time PCR system. The results were calculated according to the 2 ÀDDCT method.
| Transient transfection and construction of stable cell lines
MicroRNA mimics and FGFR4 siRNAs were purchased from Ribobio (Guangzhou, China). SNAIL siRNAs were obtained from SigmaAldrich (St Louis, MO, USA). The siRNA information is presented in Table S1 . The pCMV-SNAIL and pCMV-NC vectors were purchased from OriGene (Rockville, MD, USA). All transfections in this study were performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The miR-491-5p-overexpression retrovirus was produced as described previously.
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To construct the stable cell lines, cells were infected with a retrovirus encoding an miR-491-5p transcript and GFP or GFP alone (mock). Forty-eight hours later, puromycin was added to the medium (1 lg/mL). After 3 passages, the fluorescence of the cells was observed with a microscope, and the transfection efficiency was detected by qRT-PCR. The cells were then ready for use.
| Cell migration assay
Cell migration ability was measured using Transwell chambers (5-lm pore size, Costar, Cambridge, MA, USA). Briefly, cells were suspended in serum-free medium and seeded onto the upper chamber (1 9 10 5 cells per chamber). In the lower chamber, 300 lL of medium with 10% FCS was added as a chemoattractant. Twenty-four hours later, the cells in the upper chamber were wiped away. The cells located on the lower surface of the chamber were fixed with 4% paraformaldehyde and then stained with 0.1% crystal violet.
Then, the cells in 5 randomly selected fields were photographed under a microscope (9100). The crystal violet adhering to the cells was re-dissolved with 30% acetic acid, and the absorbance values were detected at 570 nm using a microtiter plate reader (Molecular Devices).
| Cell proliferation assay
Cells were seeded at a density of 1 
| Luciferase assays
The wild-type and mutant 3 0 -UTR of human SNAIL and FGFR4 were inserted into dual luciferase miRNA expression reporter vectors All assays were repeated independently 3 times and in quadruplicate.
| Western blotting
Western blotting was performed as described previously. The results were analyzed using the Image Lab software.
| Immunohistochemistry
The xenografts were removed from the tumor-bearing mice, paraformaldehyde-fixed, paraffin-embedded and cut into 5-lm sections. For immunohistochemistry (IHC) staining, deparaffinization, endogenous peroxidase blocking and antigen retrieval were performed sequentially on the sections. 13 Then, the sections were incubated with anti-SNAIL antibody (1:100; Abcam) and stained with HRP-conjugated IgG antibody followed by diaminobenzidine. Next, the sections were counterstained with hematoxylin and examined using a microscope (Nikon Eclipse 80i, Nikon). In addition to miR-491-5p, the miR-491 transcript produces another mature product (ie, miR-491-3p), which has been confirmed to be involved in tumor growth, metastasis and chemoresistance.
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Here, we found that the expression of miR-491-3p was also significantly downregulated in GC tissues. Overexpression of miR-491-3p
remarkably inhibited the migration of GC cells ( Figure S3 ). However, considering that the expression of miR-491-3p was much lower than that of miR-491-5p in GC tissues, we chose miR-491-5p for further investigation.
| miR-491-5p targets SNAIL directly and inhibits FGFR4 indirectly in gastric cancer cells
To date, the identities of the genes regulated by miR-491-5p in GC remain unclear. Here, the candidate target genes of miR-491-5p
were predicted with TargetScan, and then we performed microarray chip experiments using 5 pairs of GC tissues and their non-cancerous counterparts to identify the genes deregulated in GC. 8 Consider-
ing that the expression of miR-491-5p was decreased, we searched for intersections between the predicted target genes and the upregulated genes (759) on the microarray chips, and 37 genes were selected. We then analyzed the expression levels of the 37 candidates in the paired GC data from TCGA and found that 31 of the 37 genes were upregulated in the GC tissues. Among these genes, 15 candidates were selected because they were functionally related to cell metastasis (Figure 2A,B) . We then determined whether these 15 genes were inhibited by miR-491-5p. Finally, SNAIL and FGFR4
were found to be inhibited by miR-491-5p at both the mRNA and protein levels ( Figure 2C,D) . We observed that the 3 0 -UTR of SNAIL contained 3 target sites for miR-491-5p, while FGFR4 contained only 1 such site. We next constructed the luciferase reporter vectors containing the wild-type 3 0 -UTR sequences of SNAIL or FGFR4 or the mutated binding sequences of miR-491-5p ( Figure 2E ). The dual Figure S4 ). Moreover, miR-491-5p had no effect on the luciferase activity of the FGFR4 vector ( Figure 2G ). These results suggest that SNAIL is a direct target of miR-491-5p, but the inhibitory effect of miR-491-5p on FGFR4 is indirect.
We next analyzed the expression levels of SNAIL and FGFR4 in 40 pairs of GC tissues and non-cancerous tissues. The results revealed that the expression levels of SNAIL and FGFR4 were significantly upregulated in the GC tissues ( Figure 2H ). SNAIL level was inversely correlated with miR-491-5p in the GC tissues, but there was no significant correlation between FGFR4 and miR-491-5p. Moreover, there was a positive correlation between SNAIL and F I G U R E 2 miR-491-5p inhibits SNAIL and FGFR4. A, The schematic diagram presents the process and criteria used for the selection of the candidate targets of miR-491-5p. B, The heat map shows 37 genes that were both upregulated on the microarray chips and predicted to be targeted by miR-491-5p. The mRNA levels (C) and the protein levels (D) of SNAIL and FGFR4 in cells transfected with miR-491-5p mimics or mimic NC (50 nmol/L). Left, the representative western blot bands. Right, pooled data from n = 3 independent experiments. E, The wild-type and mutated binding sequences of miR-491-5p in the 3 0 -UTR of SNAIL and FGFR4. F, miR-491-5p inhibits the wild-type, but not the mutant SNAIL (Site2, position 134-140) 3 0 -UTR luciferase activity. G, miR-491-5p has no effect on FGFR4 3 0 -UTR luciferase activity. H, The relative mRNA levels of SNAIL (left) and FGFR4 (right) in 40 paired gastric cancer (GC) and normal tissues. I, Correlations of SNAIL and miR-491-5p (left), FGFR4 and miR-491-5p (middle), and SNAIL and FGFR4 (right) in the 40 GC tissues. J, Kaplan-Meier plots for SNAIL and FGFR4 in the GC cohorts. The log-rank P-values and hazard ratios (hazard ratio: 95% confidence interval in parentheses) are presented. *P < .05, **P < .01 FGFR4 in the GC tissues ( Figure 2I ). To characterize the associations of SNAIL and FGFR4 with the prognosis of GC, Kaplan-Meier survival curves were created based on the data from 876 GC patients in the KM plots database (http://kmplot.com/analysis/). 17 We found that GC patients with higher levels of SNAIL or FGFR4 had worse survival ( Figure 2J ). These results indicate that SNAIL and FGFR4 are dysregulated in GC and are correlated with GC prognosis.
| miR-491-5p-mediated SNAIL suppression reduces proliferation and migration of gastric cancer cells
To determine whether the inhibitory effect of miR-491-5p on GC cells is dependent on SNAIL, we first detected the function of SNAIL in GC cells. When SNAIL was inhibited using siRNA (Figure 3A,B) , the proliferation and migration abilities of SGC-7901 cells were significantly decreased ( Figure 3C,D) , which mimicked the effect of miR-491-5p overexpression. In contrast, the restora- SNAIL is essential for triggering EMT and promoting cancer progression. SNAIL is upregulated in GC and is associated with tumor progression and a poor prognosis. [20] [21] [22] We and others have found F I G U R E 6 Schematic depicting how decreased miR-491-5p expression promotes epithelial-to-mesenchymal transition (EMT) in gastric cancer (GC) cells and results in GC metastasis. miR-491-5p, which is downregulated in GC, directly targets SNAIL to promote the transcription of E-cadherin; meanwhile, miR-491-5p indirectly inhibits FGFR4, which results in the suppression of SNAIL and the upregulation of E-cadherin. Finally, the downregulation of miR-491-5p leads to the inhibition of SNAIL, which induces EMT and promotes GC metastasis that a series of miRNAs, including miR-22, miR-200c and miR-122, directly target SNAIL to suppress EMT and tumor progression. 8, 23, 24 Here, we identified SNAIL as a novel target of miR-491-5p. However, the details of the regulatory effect of miR-491-5p on FGFR4 require further investigation.
Currently, the upstream regulatory mechanisms of miR-491-5p
are not fully understood. miR-491-5p is reportedly induced by Foxi1 in GC cells and by TGF-b in rat proximal tubular epithelial cells and CD8 + T cells. 6, 11, 27 However, in this study, TGF-b was not able to induce miR-491-5p after 3 days of observation in either SGC-7901 or BGC-823 cells (data not shown). These discrepancies may be due to the use of different cell types. We speculate that other factors, such as transcription factors or competing endogenous RNA, may participate in the regulation of miR-491-5p expression, and this speculation requires further investigation.
The transcript of miR-491 produces 2 mature products (i.e. miR-491-5p and miR-491-3p). Li et al 3 found that both miR-491-5p and miR-491-3p suppress glioblastoma proliferation, invasion and stem cell propagation. In this study, we found that miR-491-3p was downregulated in GC and was capable of inhibiting GC cell migration. These results suggest that miR-491-5p and miR-491-3p may coordinate to play key roles in GC and even in other types of cancer.
In conclusion, because miR-491-5p has been linked to growth inhibition and apoptosis promotion in GC, we provided new evidence that miR-491-5p inhibits GC metastasis both in vitro and in vivo. Mechanistically, miR-491-5p regulated the E-cadherin/Ncadherin balance by regulating SNAIL both directly and indirectly, which resulted in the repression of EMT and GC metastasis.
Through this study, we hope to provide novel and comprehensive insights into the functional role of miR-491-5p in GC and to encourage the consideration of miR-491-5p as a putative treatment target for GC.
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